ECS Botanics Holdings Ltd has announced an agreement with German company Ilios Santé GmbH for the supply of medicinal cannabis products over three years, with a minimum revenue of $9.9 million.
The agreement will enable both companies to grow an exciting and sustainable business in Germany, Europe's largest medicinal cannabis market.
The agreement is expected to be completed once product registration has been completed.
Following the announcement, shares of Ecs Botanics Holdings (ASX:ECS) were unchanged at $0.021.